Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sruthi Ranganathan

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
The American Journal of Medicine|March 10, 2023
CME: Is it Meeting the Mark?Sruthi Ranganathan, Vinay Prasad
JAMA Surgery|March 22, 2023
Residency Research Fever Across the WorldSruthi Ranganathan, Dominique Vervoort
Journal of Cancer Policy|May 3, 2025
Minimal residual disease negative: A novel endpoint for accelerated approval; What providers should knowSruthi Ranganathan, Vinay Prasad
The Lancet. Oncology|May 2, 2024
The fate of sotorasib: a regulatory failure potentially harming patientsSruthi Ranganathan, Vinay Prasad, Timothée Olivier
Colloids and Surfaces. B, Biointerfaces|January 25, 2026
Corrigendum to "Polycaprolactone/polyvinylpyrrolidone coaxial electrospun fibers containing veratric acid-loaded chitosan nanoparticles for bone regeneration" [Colloids Surf. B Biointerfaces 193 (2020) 111110]Sruthi Ranganathan, Kalimuthu Balagangadharan, Nagarajan Selvamurugan
International Journal of Biological Macromolecules|April 20, 2019
Chitosan and gelatin-based electrospun fibers for bone tissue engineeringSruthi Ranganathan, Kalimuthu Balagangadharan, Nagarajan Selvamurugan
European Journal of Cancer (Oxford, England : 1990)|July 3, 2024
CDK4/6 inhibitors as adjuvant therapy in early breast cancer? Uncertain benefits, guaranteed harmsAlyson Haslam, Sruthi Ranganathan, Vinay Prasad, et al.
Journal of Cancer Policy|December 7, 2023
Characteristics and outcomes of new molecular oncology drug approvals, in combination or monotherapySruthi Ranganathan, Alyson Haslam, Jordan Tuia, et al.
Translational Oncology|May 21, 2025
FRESCO-2 trial and fruquintinib: A clearer picture of the control armSruthi Ranganathan, Alyson Haslam, Timothée Olivier, et al.
Journal of Cancer Policy|June 9, 2024
Social media engagement of supportive care publications in oncologySruthi Ranganathan, David J Benjamin, Alyson Haslam, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
The American Journal of Medicine|March 10, 2023
CME: Is it Meeting the Mark?Sruthi Ranganathan, Vinay Prasad
JAMA Surgery|March 22, 2023
Residency Research Fever Across the WorldSruthi Ranganathan, Dominique Vervoort
Journal of Cancer Policy|May 3, 2025
Minimal residual disease negative: A novel endpoint for accelerated approval; What providers should knowSruthi Ranganathan, Vinay Prasad
The Lancet. Oncology|May 2, 2024
The fate of sotorasib: a regulatory failure potentially harming patientsSruthi Ranganathan, Vinay Prasad, Timothée Olivier
Colloids and Surfaces. B, Biointerfaces|January 25, 2026
Corrigendum to "Polycaprolactone/polyvinylpyrrolidone coaxial electrospun fibers containing veratric acid-loaded chitosan nanoparticles for bone regeneration" [Colloids Surf. B Biointerfaces 193 (2020) 111110]Sruthi Ranganathan, Kalimuthu Balagangadharan, Nagarajan Selvamurugan
International Journal of Biological Macromolecules|April 20, 2019
Chitosan and gelatin-based electrospun fibers for bone tissue engineeringSruthi Ranganathan, Kalimuthu Balagangadharan, Nagarajan Selvamurugan
European Journal of Cancer (Oxford, England : 1990)|July 3, 2024
CDK4/6 inhibitors as adjuvant therapy in early breast cancer? Uncertain benefits, guaranteed harmsAlyson Haslam, Sruthi Ranganathan, Vinay Prasad, et al.
Journal of Cancer Policy|December 7, 2023
Characteristics and outcomes of new molecular oncology drug approvals, in combination or monotherapySruthi Ranganathan, Alyson Haslam, Jordan Tuia, et al.
Translational Oncology|May 21, 2025
FRESCO-2 trial and fruquintinib: A clearer picture of the control armSruthi Ranganathan, Alyson Haslam, Timothée Olivier, et al.
Journal of Cancer Policy|June 9, 2024
Social media engagement of supportive care publications in oncologySruthi Ranganathan, David J Benjamin, Alyson Haslam, et al.
Pageof 9